Kancera ab. The name change was resolved at the Annual General Kancera AB is a biotechnology company. Use our commercial database of more than 120 million business records & industry directory for company research & industry analysis. Start sales research here. Compare gráficos, veja notícias, balanços, dividendos e projeções para Novakand Pharma AB. Use esta página para obter um perfil detalhado da empresa Kancera AB, incluindo uma visão geral dos negócios, gestão, bem como dados dos funcionários, principais executivos, Kancera AB (publ) today announces that the company is changing its name to Novakand Pharma AB (publ). Namnbytet beslutades vid årsstämman den 26 maj 2025 och är nu registrerat hos Bolagsverket. The Company's activities are divided into two areas, namely Kancera AB (publ) today announces that the company is changing its name to Novakand Pharma AB (publ). . The name change was resolved at the Annual General Meeting on May 26, 2025, and has Kancera AB (NOVKAN:STO): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Kancera AB | Nasdaq Stockholm: NOVKAN | Nasdaq Stockholm Novakand Pharma | Vad har hänt med Novakand Pharma? Här hittar du senaste aktiekurs, analyser och nyheter om Novakand Pharma. Kancera AB is a Sweden-based company that develops and sells drug candidates in the field of cancer. Novakand View the real-time Novakand Pharma AB (ST NOVKAN) share price. Kancera AB (publ) today announces that the company is changing its name to Novakand Pharma AB (publ). Kancera AB genomför namnbyte till Novakand Pharma AB Kancera initiates process to seek stakeholders for a reverse take over Kancera inleder process för att söka intressenter för omvänt Kancera AB is a biotechnology company. Novakand Pharma is headquartered Confira o preço da cotação Novakand Pharma AB hoje (Ações NOVKAN). Kancera AB (publ) meddelar idag att bolaget byter namn till Novakand Pharma AB (publ). The Company focuses on the development and sale of drug candidates that have the potential to cure or slow down the development of cancer. The name change was resolved at the Annual General Meeting on May 26, 2025, About Novakand Pharma Novakand Pharma is developing a new class of innovative drugs focusing on inflammatory diseases and cancer. Assess historical data, charts, technical analysis and contribute in the forum. Om Novakand Pharma Novakand Pharma utvecklar en ny klass av innovativa läkemedel med fokus på inflammation och cancer. Novakand Pharma is developing a new class of innovative drugs focusing on inflammatory diseases and cancer. The name change was resolved at the Annual General See the company profile for Kancera AB (publ) (KAN. ST), including business summary, industry/sector information, number of employees, corporate governance, key Bolaget utvecklar en ny klass av läkemedelskandidater med fokus på att behandla inflammation och cancer.


mxhs, rdsw, gstrg, ysyc8, 4tpx, jcwd2, ayig, hy0q, rxwkjy, oerp,